期刊文献+

HIF-1α和P53蛋白的表达对肾透明细胞癌预后的影响 被引量:4

Effect of hypoxia inducible factor-1 alpha and P53 expression on prognosis of clear cell renal cell Carcinoma
暂未订购
导出
摘要 目的本研究旨在探讨缺氧诱导因子1α(HIF-1α)和P53蛋白在人肾透明细胞癌组织中的表达及其对患者预后的影响。方法应用免疫组化方法检测65例肾透明细胞癌组织中HIF-1α和P53蛋白的表达情况,通过生存曲线法比较阳性组和阴性组患者的预后情况。结果 HIF-1α和P53蛋白表达的阳性率分别为40.0%(26/65)和52.3%(34/65);HIF-1α表达与肾透明细胞癌的组织学分级、临床分期和淋巴结转移有关(P<0.05);HIF-1α蛋白阳性组患者的生存期明显较阴性组短(P=0.004);P53蛋白表达与肾透明细胞癌患者性别、年龄、肿瘤大小、组织学分级、临床分期、淋巴结转移及生存期均无关(P>0.05);HIF-1α蛋白P53蛋白的表达之间存在相关性(r=0.402,P=0.001)。结论 HIF-1α的表达与肾透明细胞癌患者的预后相关,其阳性表达提示患者预后不良;检测HIF-1α表达水平有助于肾细胞癌预后评估。 Objective This study was designed to investigate the expression of HIF-1α and P53,and their effect on prognosis of clear cell renal cell carcinoma(ccRCC).Methods SP immunohistochemistry was used to determine the expression of HIF-1α and P53 in patients with ccRCC.Kaplan-Meier and Log-rank test were used to compare the survival time of positive staining group and negative staining group.Results The positive rate of HIF-1α and P53 was 40.0% and 52.3%,respectively.The positive expression of HIF-1α was related to the clinical stage,histological grade and lymph node metastasis of ccRCC(P0.05).The survival time in positive HIF-1α group was significantly shorter than that in negative HIF-1α group(P=0.004).The positive expression of P53 was not related to the age,sex,tumor size,clinical stage,histological grade,lymph node metastasis and survival time(P0.05).There was significant correlation between HIF-1α and P53 in ccRCC(r=0.402,P=0.001).Conclusion The expression of HIF-1α was closely correlated with the prognosis of ccRCC,and the positive expression of HIF-1α suggested poor prognosis in patients with ccRCC.Examination of HIF-1α expression may be useful for predicting prognosis.
出处 《现代泌尿外科杂志》 CAS 2010年第6期435-439,共5页 Journal of Modern Urology
关键词 肾肿瘤 缺氧诱导因子-1Α P53 预后 免疫组织化学 renal neoplasms hypoxia inducible factor-1alpha P53 prognosis immunohistochemistry
  • 相关文献

参考文献16

  • 1SEMENZA GL.Targeting HIF-1 for cancer therapy[J].Nat Rev Cancer,2003,3(10):721-732.
  • 2ZHONG H,DEMARZO AM,LAUGHNER E,et al.Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases[J].Cancer Res,1999,59(22):5830-5835.
  • 3BRINER P,SCHINDL M,OBERMATR A,et al.Overexpression of hypoxia inducible factor-1 alpha is a marker for an unfavortable prognosis in early stage invasive cervical cancer[J].Cancer Res,2000,60(17):4693-4695.
  • 4AEBERSOLD DM,BURRIP P,BEER KT,et al.Expression of hypoxia-inducible factor-1 alpha:A novel predictive and prognostic parameter in the radiotherapy of otopharyngeal cancer[J].Cancer Res 2001,61(7):2911-2916.
  • 5TOBIAS K,DAVID S,STEPHEN R,et al.Hypoxia Inducible Factor 1α in Clear Cell Renal Cell Carcinoma[J].Clin Cancer Res,2007,13,7388-7393.
  • 6GU Z,FLEMINGTON C,CHITTENDEN T,et al.A p53 response gene involved in growth suppression and apoptosis[J].Mol Cell Biol,2000,20(1):233-241.
  • 7赵坡,许红民,李晓瑛,王德文,毛新,李维华.肾细胞癌P53、c-erbB-2癌蛋白高表达与预后的关系[J].中华泌尿外科杂志,1995,16(8):457-459. 被引量:6
  • 8KERNEL D,HUJANEN IT,VAHAKANAS K,et al.Proliferation cell nuciearantigen but not p53 or human papillonmvims DNA correlates advanced clinical stage in renal cell carcinoma.[J].Histopathology,1994,25:239.
  • 9LIPPONEN P,ESKELINEN M,SYRIANEN H.Expression of proliferating cell nuclear antigen(PCNA),P53 Protein and cerb-2 in renal adcnocarcinoma[J].Inf J Cancer,1994,57(2):275-280.
  • 10TOYOAKI Uchida,Jiangping GAG,Chunxi WANG et al.Clinical siginifance of p53,mdm2,and bcl-2 proteins in renal cell carcinoma[J].Urology,2002,59(4):615-620.

二级参考文献10

  • 1顾方六,肾肿瘤[M]//吴阶平.泌尿外科学.上卷.济南:山东科学技术出版社,2004:895-896.
  • 2Masuda H, Kurita Y, Suzuki A, et al. Prognostic factors for renal cell carcinoma: a multivariate analysis of 320 cases [J]. Urology, 1997, 4(4):247-252.
  • 3Takashi M, Kawai T, Murase T, et al. Multivariate evaluation of prognostic determinants for renal cell carcinomas which are metastatic at initial diagnosis [J]. Urol Nephrol, 1997, 29(6):291-300.
  • 4Giberti C, Oneto F, Martorana G, et al. Radical nephrectomy for renal cell carcinoma: long term results and prognostic factors on a series of 328 cases [J]. Eur Urol, 1997, 31(1) :40-48.
  • 5Gitterio G, Bertuzzi A, Tresoldi M, et al. Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients [J]. Eur Urol, 1997, 31 (8) :286-291.
  • 6Kuczyk MA, Bokemeyer C, KEhn G, et al. Prognostic relevance of intracaval noeplastic extension for patients with renal cell cancer [J]. Br J Urol, 1997, 80(1):18-24.
  • 7Wood DD. Role of lymphadenectomy in renal cell carcinoma [J]. Urol Clin North Am, 1991, 18(2):421-426.
  • 8Fisher RI, Rosenberg SA. Long-term survival update for highdose recombinant interleukin-2 in patients with renal cell carconima [J]. Cancer J Sci AM, 2000, 6(Suppl 1):SSS-S7.
  • 9Stebbing J, Gore M. The current status of interferon-alpha treatment in advanced renal cancer [J]. BJU Int, 2001, 87(7) : 599-601.
  • 10骆福添,胡孟璇.Cox模型在肿瘤预后因素分析中的应用[J].癌症,1991,10(1):84-87. 被引量:24

共引文献15

同被引文献46

  • 1Vaupel P. Hypoxia and aggressive tumor phenotype: im- plications for therapy and prognosis [J]. Oncologist,2008 (3) : 21 -26.
  • 2Bordoli MR, Stiehl DP, Borsig L, et al. Protyl-4-hydrox- ylase PHD2 and hypoxia-inducible factor 2-dependent reg- ulation of amphiregulin contributes to breast tumorigenesis [J]. Oneogene, 2011(5): 548-560.
  • 3Bertout JA, Patel SA, Simon MC. The impact of O2 avail- ability on human cancer [ J]. Nat Rev Cancer, 2008 (12): 967 -975.
  • 4Liu G, Yang G, Chang B, et al. Stanniocalcin 1 and ovar- ian tumorigenesis [J]. J Natl Cancer Inst, 2010( 11 ) : 812 - 827.
  • 5Gort EH, Groot A J, van der Wall E, et al. Hypoxic regu- lation of metastasis via hypoxia-inducible factors [ J ]. Curr Mol Med, 2008 (8) : 60 - 67.
  • 6Manolescu B, Oprea E, Busu C, et al. Natural com- pounds and the hypoxia-inducible factor (HIF) signaling pathway [ J]. Biochimie, 2009( 11 ) :1347 - 1358.
  • 7Semenza GL. Defining the role of Hypoxia-inducible fac- tor 1 in cancer biology and therapeutics [ J]. Oncogene, 2010 (5) :625 - 634.
  • 8Lal A, Peters H, St Croix B, et al. Transcriptional re- sponse to hypoxia in human tumors [ J]. J Natl Cancer Inst, 2001 (17) : 1337 - 1343.
  • 9Neumann AK, Yang J, Biju MP, et al. Hypoxia induc- ible factor 1 alpha regulates T cell receptor signal trans- duction [J]. Proc Natl Acad Sci USA, 2005(47) :17071 - 17076.
  • 10He LF, Wang TI', Gao QY, et al. Stanniocalcin-1 pro- motes tumor angiogenesis through up-regulation of VEGF in gastric cancer cells [J]. J Biomed Sci, 2011 (39) :145 - 151.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部